Instil Bio
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2018-01-01
- Employees
- 18
- Market Cap
- $83.7M
- Website
- http://www.instilbio.com
- Introduction
Till Capital Corp is a holding company operating through the insurance segment. Through its subsidiaries, it conducts the insurance and reinsurance business. Its geographical segments are Canada, and United States. The company operates in a single segment, that being investments.
ITIL-306 in Advanced Solid Tumors
Phase 1
Active, not recruiting
- Conditions
- Epithelial Ovarian CancerNon-small Cell Lung CancerRenal Cell Carcinoma
- Interventions
- Biological: ITIL-306
- First Posted Date
- 2022-05-31
- Last Posted Date
- 2024-03-05
- Lead Sponsor
- Instil Bio
- Target Recruit Count
- 51
- Registration Number
- NCT05397093
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸Washington University School of Medicine, Saint Louis, Missouri, United States
ITIL-168 in Advanced Solid Tumors
Phase 1
Withdrawn
- Conditions
- Cervical CancerNon-small Cell Lung CancerHead and Neck Squamous Cell Carcinoma
- Interventions
- Biological: ITIL-168
- First Posted Date
- 2022-05-26
- Last Posted Date
- 2022-12-20
- Lead Sponsor
- Instil Bio
- Registration Number
- NCT05393635
ITIL-168 in Advanced Melanoma
Phase 2
Terminated
- Conditions
- Advanced Cutaneous Melanoma
- Interventions
- Biological: ITIL-168
- First Posted Date
- 2021-09-20
- Last Posted Date
- 2024-04-16
- Lead Sponsor
- Instil Bio
- Target Recruit Count
- 29
- Registration Number
- NCT05050006
- Locations
- 🇺🇸
University of California San Diego, Moores Cancer Center, La Jolla, California, United States
🇺🇸Georgetown University Medical Center, Washington, District of Columbia, United States
🇺🇸St. Luke's University Health Network, Bethlehem, Pennsylvania, United States
© Copyright 2025. All Rights Reserved by MedPath